Pharmaceutical market research for small teams: settle safety reporting first

Pharmaceutical market research on a small team: read free trial and label data, interview prescribers and payers, and plan adverse event reporting first.

Instant Expert EditorialPublished Updated 5 min read

Pharmaceutical market research is how a company learns the market for a medicine: how patients are treated today, which products compete, who decides what gets prescribed and paid for, and what would make prescribers switch. A small team can run a useful first round with free trial and approval data plus interviews with prescribers, pharmacists and payer staff. The one step you cannot skip is deciding, before the first call, how you will handle adverse events that participants mention.

If you sell software or services to drug companies, that is ordinary business-to-business research. Skip to the section near the end.

A made-up biotech to keep this concrete

Say a small biotech has an injectable treatment in mid-stage trials for a chronic skin condition. It wants to know how specialists choose between current treatments, why patients switch, and what payers require before covering a newer option. This example is hypothetical.

1. Read the free government data first

ClinicalTrials.gov describes itself as the world's largest database of privately and publicly funded clinical studies. Records show what is studied, who can take part and where. Sponsors supply the information, and a listing does not mean the government has evaluated the study (NLM fact sheet). Search the condition to see who is testing what, and at which stage.

Drugs@FDA covers approved products, including approval histories. The approved label describes what a drug is used for, who should take it, side effects and safety information (FDA glossary). Current labels give you the vocabulary prescribers use and the claims you will be compared against. See secondary market research.

2. Interview the people who prescribe, dispense and pay

EPHMRA, a European pharmaceutical market research association, defines a healthcare professional broadly: anyone licensed in medicine, dentistry, pharmacy or nursing, or anyone who administers, prescribes, purchases, recommends or supplies a medicine, which can include a payer with budget responsibility (EPHMRA guidelines). For the biotech, interview:

  • Prescribers: dermatologists who treat the condition often, academic and community.
  • Pharmacists and nurses: people who handle injections, refills and patient questions.
  • Payer and access staff: people who write or apply coverage rules for the drug class.

Ask about patterns, never one patient: "When a patient stops responding to the first treatment, what do you usually try next, and why?" More prompts in questions for an unfamiliar industry.

3. Settle adverse event reporting before the first call

If your company holds the license for a medicine discussed in the research, industry guidelines expect you to capture adverse events that come up and pass them on. EPHMRA's guidelines say:

  • Participants are told about the reporting duty at recruitment and again at the start of the interview.
  • Adverse events reach the company's safety team within one business day.
  • A report needs an identifiable reporter, an identifiable patient or group of patients, a suspected product and a suspected event.
  • The duty does not apply to products whose license the commissioning company does not hold.
  • Personal details go to the safety team only with consent or another lawful basis, with country exceptions such as Germany.

Still in trials? Ask your safety (pharmacovigilance) lead how this applies. With marketed products, agree the process with that team before recruiting, as the Insights Association recommends.

Short version: decide who reports what, and to whom, before a participant starts a sentence with "One of my patients had a reaction..."

4. Be careful how you pay physicians

The U.S. Sunshine Act requires drug and device manufacturers to report many payments to physicians. Research payments made through a third party are excluded when the manufacturer does not know the physician's identity, and the Insights Association argues identities should not go to the sponsor without consent. A manufacturer planning to pay physicians directly should get legal advice first. For the amount, see the research incentive budget guide.

If you sell to drug companies instead

Selling, say, trial-management software to drug companies means researching buyers, so B2B market research applies. Their staff may have their own safety-reporting duties, so say at the start that you are not asking about specific patients or products. Check with counsel if you are unsure how this applies.

Instant Expert can send the invitations for you. Name specific people or describe the experience you need, review who it finds, and write a note that says up front you won't ask about patients or products. You set what each person receives, and our fee (20% of what you pay) is added on top: a $200 offer for a 30-minute call costs you $250, charged only if they book or answer. Each person has 7 days to book a 15, 30, 45 or 60 minute call or send a written or voice answer, and declines cost nothing. See product professionals in pharmaceuticals, procurement professionals in pharmaceuticals and operations professionals in clinical research.

If you work in pharma and receive an invitation

The amount shown is what you receive; the sender pays our fee on top. Answer from your own experience and keep your employer's confidential information out of it. If your employer limits paid outside work, check its policy before you accept. You can also have the amount donated to a charity you pick; we make the donation for you. Every invitation has a link to stop future requests.

Write the decision down first

Name the decision this research should inform, settle reporting and payment rules with your safety and legal leads, and only then recruit. If you know the roles you need, start a search with a one-sentence description of the experience.

A first round of pharmaceutical market research

  1. 1

    Read public data

    Check trial records and approved labels for the condition and current treatments.

  2. 2

    Pick participants

    Choose prescribers, pharmacists or nurses, and payer or access staff.

  3. 3

    Settle reporting

    Agree adverse event and payment handling with safety and legal leads.

  4. 4

    Interview

    Ask about treatment patterns and switching, not about individual patients.

  5. 5

    Summarize

    Compare what each group said about why treatments start, stop and get covered.

Public data frames the market, interviews explain treatment and coverage decisions, and reporting rules get settled before anyone is recruited.